Gene · 23327
Papers2,568
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,568
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MX1 promotes gastric cancer cell migration via inhibiting ANXA2 ubiquitination and degradation. | Biochim Biophys Acta Mol Basis Dis | 2027 | 42641668 | PubTator, text mining | PubMed |
| Nav1.5 Beyond Genetics: Loss of Cardiac Sodium-Channel Function in Brugada Syndrome. | Europace | 2026 | 42758283 | PubTator, text mining | PubMed |
| Propofol alleviates OGD/R-induced cerebral ischemia-reperfusion injury-related neuronal injury by regulating NEDD4L-mediated ubiquitination of HTR2B. | Biochem Biophys Res Commun | 2026 | 42748874 | PubTator, text mining | PubMed |
| Activation of serum and glucocorticoid-induced kinase 1 promotes the release of coronavirus infectious bronchitis virus particles in cultured cells. | Vet Microbiol | 2026 | 42743771 | PubTator, text mining | PubMed |
| SGK2 Promotes NEDD4L-Mediated ACSL4 Ubiquitination to Inhibit Ferroptosis and Alleviate Diabetic Kidney Disease. | Antioxid Redox Signal | 2026 | 42730475 | PubTator, text mining | PubMed |
| Real-world pharmacogenomics-guided antihypertensive treatment response in clinical practice underrepresented population: implications for precision prescribing and medication safety. | Eur J Clin Pharmacol | 2026 | 42722881 | PubTator, text mining | PubMed |
| RIBOTAC-mediated degradation of hsa-microRNA-301a-3p suppresses TNBC bone metastasis. | Sci Adv | 2026 | 42647607 | PubTator, text mining | PubMed |
| Expanding the clinical and molecular spectrum of SETD5, NEDD4L, and TBL1X related disorders: A case report and literature review. | Gene | 2026 | 42595145 | PubTator, text mining | PubMed |
| Quercetin inhibits breast cancer progression by inducing ferroptosis via the NEDD4L-SLC7A11 axis. | Gen Physiol Biophys | 2026 | 42583684 | PubTator, text mining | PubMed |
| Nutritional and dietary drivers in the pathogenesis of acute appendicitis: the nutrition-microbiome-genetic axis. | Proc Nutr Soc | 2026 | 42396694 | PubTator, text mining | PubMed |
| Unanswered questions on palmitic acid-driven neuroimmune inflammation in atopic dermatitis: a commentary on Chen et al. | Inflamm Res | 2026 | 42384050 | PubTator, text mining | PubMed |
| Natural small molecule evodiamine alleviates liver fibrosis by targeting the ANXA2-p110α axis in hepatic stellate cells. | Phytomedicine | 2026 | 42361759 | PubTator, text mining | PubMed |
| Adaptor-mediated interaction between Kv1.3 and Nedd4-2 E3 ubiquitin ligase. | Commun Biol | 2026 | 42337377 | PubTator, text mining | PubMed |
| MET-mediated phosphorylation of YANK2 at Y282 inhibits NEDD4L-dependent SUMOylation and degradation, promoting chemoresistance in glioblastoma. | Mol Biomed | 2026 | 42337173 | PubTator, text mining | PubMed |
| NEDD4L suppresses colorectal cancer metastasis and immune escape by inhibiting STAT3 signaling. | Tissue Cell | 2026 | 42335647 | PubTator, text mining | PubMed |
| The splicing factor hnRNPA1 promotes osimertinib resistance in lung adenocarcinoma by regulating NEDD4L alternative splicing. | Oncogene | 2026 | 42321531 | PubTator, text mining | PubMed |
| PUM2 inhibits ferroptosis and enhances oxaliplatin resistance in COAD via the NEDD4L/NRF2 axis. | Transl Oncol | 2026 | 42314512 | PubTator, text mining | PubMed |
| When neuroligin-2 sticks around, astrocytes take shape. | J Cell Biol | 2026 | 42313095 | PubTator, text mining | PubMed |
| SerpinB7 promotes c-Myc-mediated glycolysis by interacting with ANXA2 to facilitate the progression of non-small cell lung cancer. | Mol Cancer | 2026 | 42310746 | PubTator, text mining | PubMed |
| HECT E3 ubiquitin ligase SMURF2 orchestrates FcεRI-dependent mast cell activation and allergic responses. | J Allergy Clin Immunol | 2026 | 42285366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23327/papers